Comparison of Otezla to SFA-002 to Placebo in Plaque Psoriasis Patients

Clinical trial NCT06863493 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06863493
Sponsor: SFA Therapeutics
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Psoriasis (PsO)

Start date: 2025-06-01
Primary completion: 2026-06-01
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.